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Abstract 
While attempting to improve production of fluoro-iturin A in Bacillus sp. CS93 new mono- 
and di-fluorinated fengycins were detected in culture supernatants by 19F NMR and tandem 
mass spectrometry, after incubation of the bacterium with 3-fluoro-L-tyrosine.  The 
fluorinated amino acid was presumably incorporated in place of one or both of the tyrosyl 
residues in fengycin.  Investigations to generate additional new fluorinated derivatives were 
undertaken using commercially available fluorinated phenylalanines and 2-fluoro- and 2,3-
difluoro-tyrosine that were synthesised by Negishi cross-coupling of iodoalanine and 
fluorinated bromo-phenols.  The antifungal activity of the fluorinated lipopeptides was 
assayed against Trichophyton rubrum and found to be similar to that of the non-fluorinated 
metabolites. 
Keywords: Antibiotic, Bacillus, fluorine, tyrosine  
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Introduction 
Several Bacillus spp. produce the antimicrobial lipopeptides surfactin, iturin and fengycin 
(Chen et al. 2008).  These compounds are produced via non-ribosomal peptide synthases and 
are composed of a cyclised peptide and an alkyl chain of varying lengths, as illustrated in 
Figure 1 (Koumoutsi et al. 2004).  The antimicrobial activities of the lipopeptides are of 
considerable interest, and the producing bacteria are used as environmentally-friendly 
biocontrol agents to inhibit plant pathogens, e.g. Serenade  from Agraquest and 
FZB24®TB from ABiTEP GmbH are both formulations containing lipopeptide-producing 
strains of B. subtilis.  The general mechanism for the antimicrobial activity of the different 
lipopeptides is permeabilisation of cell membrane, particularly of fungi; however, the 
interactions are somewhat different for each peptide type (Bonmatin et al. 2003).  Iturin A 
interacts with sterols in fungal membranes via the phenolic OH of tyrosine, surfactin behaves 
as a powerful surfactant and fengycins inhibit phospholipase and forms pores in membranes, 
resulting in leakage (Tao et al. 2011). 
Bacillus sp. CS93 was originally isolated from pozol (Ray et al. 2000), a Mayan 
fermented product that was consumed as a food and used as a treatment for intestinal 
complaints and skin infections.  The strain is known to produce the dipeptides bacilysin and 
chlorotetaine, plus the lipopeptides iturin A, surfactin and fengycin (Phister et al. 2004; 
Moran et al. 2010); it is likely that the antimicrobial properties of these compounds are 
responsible in part for the curative properties of pozol.  The substrate flexibility of the 
biosynthetic machinery involved in lipopeptide production has enabled precursor directed 
incorporation of 3-fluorotyrosine and 4,4,4-trifluorovaline into iturin A and surfactin, 
respectively (Moran et al. 2009; O'Connor et al. 2012).  Approximately 20 % of currently 
available pharmaceuticals and 30 % of agrochemicals contain fluorine, which can alter 
3 
 
compounds’ properties such as lipophilicity and metabolic stability, thereby improving their 
biological activity (Murphy et al. 2009).  Incorporation of fluorine into lipopeptides might 
have an influence on biological activity, for example, the hydroxyl group of the tyrosyl 
residue in iturin A plays an important role in binding to fungal membranes (Volpon et al. 
1999), and the acidity of the group will be altered with the presence of fluorine.  
Additionally, fluorinated compounds might be useful as probes for fluorine-19 NMR studies 
of membrane interactions and receptor binding (Cobb and Murphy 2009).  In this paper the 
incorporation of various fluorinated amino acids into fengycin and iturin, and an assessment 
of some of their biological properties are reported. 
 
CH3(CH2)12
Fengycin
Iturin A
 
Fig. 1. Structures of C-16 fengycin and C-14 iturin A. 
4 
 
Results and Discussion 
In our previous study (Moran et al. 2009) we demonstrated that fluorinated iturin had anti-
fungal activity, but the limited amount of material available at the time prevented any 
quantitative assessment.  So that more rigorous evaluation of the biological properties of 
fluorinated iturin A could be conducted, attempts were made to up-scale production of this 
metabolite by modifying the growth conditions of the producing strain (Bacillus sp. CS93) 
using a growth medium optimised for lipopeptide production (Ahimou et al. 2000) and 
increasing the culture volume by employing multiple culture vessels.  Fluorinated iturins 
were detectable in crude methanolic extracts by electrospray mass spectrometry (Table 1), 
and C-14 fluoroiturin was detected in the highest concentration (0.5 mg L-1) by HPLC.  
Purification of this analogue was achieved by semi-preparative HPLC generating a 1:1 iturin 
A:fluoro-iturin mixture, but total separation was not possible using this method. 
Table 1.  Ions from ESI-MS analysis of lipopeptides produced by Bacillus sp. CS93 cultures 
incubated with 3-fluoro-L-tyrosine. 
Chain length [M+Na+] [F+M+Na+] [2F+M+Na+] 
C-14 Iturin A 1065.58 1083.42 N/A 
C-15 Iturin A 1079.61 1097.60 N/A 
C-16 Iturin A 1093.17 1111.18 N/A 
Chain length [M+H+] [F+M+H+] [2F+M+H+] 
C-14 Fengycin A 1435.95  1453.84  1471.68  
C-15 Fengycin A 1449.95  1467.72  1485.83  
C-16 Fengycin A 1463.90  1481.81  1499.67  
C-17 Fengycin A 1477.84  1495.75  1513.83  
C-18 Fengycin A 1491.85 1509.76 1527.86 
 
Attempts were also made to broaden the diversity of the fluorinated iturins produced by 
Bacillus sp. CS93 by conducting feeding experiments with other fluorinated phenylalanines 
and tyrosines.  No incorporation was detected with 2-fluorophenylalanine or 3,4- and 3,5-
difluorophenylalanine; HR-MS analysis of HPLC-purified lipopeptide from cultures fed with 
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4-fluoro-L-phenylalanine revealed an ion m/z 1081.5422 that was not present in cultures 
grown in the absence of the amino acid and has the expected mass of a sodiated C-15 iturin A 
analogue in which tyrosine has been replaced with fluorophenylalanine (1081.5458).  
Furthermore, a new resonance was also observed by 19F-NMR (F -118.8 ppm), 
approximately 2 ppm upfield from that of the precursor (not shown).  Therefore, it is likely 
that a very small incorporation of 4-fluorophenylalanine had occurred in place of tyrosine.  
However, not enough was formed to warrant any attempt at further purification.  The known 
fluorinated amino acids 2-fluorotyrosine 7 (Kim et al. 1998) and 2,3-difluoro-tyrosine 8 (Kim 
et al. 1998) were synthesised using a Negishi cross-coupling of iodoalanine and fluorinated 
bromo-phenols as the key step (Scheme 1).  The Negishi cross-coupling conditions used to 
prepare compounds 5 and 6 have been previously shown to preserve the stereochemical 
integrity of the alpha-carbon (Colgin et al, 2011).  However, no incorporation into iturin A 
was detected when these compounds were fed to Bacillus sp. CS93, suggesting that either 
these precursors are not substrates for the adenylation reaction in place of tyrosine, or their 
incorporation into the growing peptide results in inhibition of downstream reactions. 
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L-serine
i) ii)
1
iii)
2
iv)
3, R1=F, R2=H
4, R1, R2=F
5, R1=F, R2=H
6, R1, R2=F
7, R1=F, R2=H
8, R1, R2=F
v)
vi)
 
Scheme 1 i H2O, THF, NaOH, di-tert-butyl dicarbonate ii DMF, K2CO3, benzyl bromide iii 
DCM, PPh3, imidazole, I2 iv DMF, Zn, I2, Pd2(dba)3, SPhos v MeOH, HCl vi EtOAc, Pd, H2 
 
 In the extracts from cultures that had been fed with 3-fluoro-L-tyrosine resonances 
were observed by 19F NMR that had not previously been seen (Fig 2).  These were initially 
thought to be gratuitous biotransformation products unrelated to lipopeptide biosynthesis, but 
closer inspection of the ESI-MS spectra indicated that the precursor is being incorporated into 
fengycin, a lipopeptide also known to be produced by this strain (Moran et al. 2010).  Ions 
that were 18 and 36 Daltons heavier than the expected masses of C14-C17 fengycins were 
observed (Table 1) and as fengycin contains two tyrosyl residues (residues 3 and 9, Figure 1), 
both singly and doubly fluorinated fengycin can conceivably be produced.  To enable further 
characterisation, 4 mg of putative C-16 and 1 mg of C-17 monofluorofengycin (m/z 1482.05, 
1495.75, respectively) were purified from 2 L of culture by a combination of acid 
precipitation, solid phase extraction and semi-preparative HPLC.  19F NMR analysis of the C-
16 analogue revealed two resonances (Fig 2), suggesting fluorotyrosine incorporation into 
either of the two positions, although not to the same degree, since the resonance δ -143.3 ppm 
is greater than at δ -131 ppm (4:1 ratio).  The presumed C-16 metabolites were subjected to 
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analysis by tandem MS (Fig 3A) and the fragmentation compared with that of non-
fluorinated C-16 fengycin (Wang et al. 2007; Li et al. 2012).  Key fragment ions were 
detected that were 18 mass units heavier than the corresponding fragments of natural C-16 
fengycin.  Loss of water is observed yielding m/z 1464 and the product ion m/z 1227 results 
from the loss of the acyl chain; m/z 1098 and 984 correspond to the neutral loss of [acyl 
chain-Glu] and [acyl chain-Glu-Orn], respectively (Fig 3B).  Whilst these fragments are 
consistent with the incorporation of fluorotyrosine, they do not indicate the location of the 
residue.  Wang et al. (2007) detected a major ion m/z 966 in the CID spectrum of fengycin, 
and deduced it to be Pro-Gln-Tyr-Ile-Tyr-Thr-Glu-Ala (Fig 3C).  The fluorinated equivalent 
m/z 984 is apparent in Fig 3A together with smaller ions, notably m/z 389, which was also 
observed in the CID of non-fluorinated C-16 fengycin, and is Pro-Gln-Tyr.  Thus, it can be 
inferred that the fluorotyrosine is predominantly incorporated in position 3 of the lipopeptide.  
Whilst ion m/z 407 is present, arising from fluorotyrosine in position 9, its abundance relative 
to that of m/z 389 is much lower and reveals that the minor resonance δ -131 ppm observed 
by 19F NMR is most likely due to the small quantities of this fluorofengycin isomer.  These 
data strongly suggest that fluorotyrosine is preferentially incorporated into position 3 of the 
fengycin peptide.  Interestingly, the overall degree of incorporation is greater than that into 
iturin A (Fig 2); the stereochemistries of the tyrosine residue of iturin A and position 9 of 
fengycin are both D, as a consequence of epimerisation reactions after incorporation, whereas 
residue 3 of fengycin retains the L-configuration.  Therefore, the relatively poor incorporation 
of fluorotyrosine into iturin A or residue 9 of fengycin may be influenced by the 
epimerisation step rather than adenylation.  1H NMR analysis of the natural fengycin revealed 
2H tyrosine doublets (δH 7.14, d, J = 8.4 Hz; δH 6.70, d, J = 8.4 Hz) for one of the tyrosine 
residues and another doublet (δH 7.07, d, J = 8.4 Hz) plus a broad singlet (7.20 ppm) for the 
other tyrosine residue.  In the 1H NMR spectrum of the fluorofengycin, the doublets were 
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replaced with multiplets at 7.07, 7.03, 6.90, 6.82 and 6.67 ppm, indicative of the presence of 
two different fluorofengycins in which one or the other tyrosine had been substituted with 
fluorotyrosine.  ESI-MS also detected a faint ion at m/z 1427.90 in culture supernatants after 
feeding Bacillus sp. CS93 with 2,3-difluoro-L-tyrosine 8, suggesting the production of trace 
amounts of difluorofengycin.  The same ion was not detected in control experiments in which 
the fluorinated amino acid was incubated in the absence of bacterium. 
 
Fig. 2.  19F NMR spectra of lipopeptide extract from Bacillus sp CS93 after incubation with 
3-fluorotyrosine (bottom) and purified C-16 fluorofengycin (top).  The starting material, 3-
fluorotyrosine, and fluorinated iturin can be seen in the crude extract at δF -142.7 and -142.95 
ppm, respectively.  The purified fluorofengycin has two resonances (δF -131.3, -143.3) 
indicating that 3-fluorotyrosine is incorporated in place of one or other of the tyrosine 
residues in the lipopeptide. 
 
 
Antifungal testing 
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The biological activity of the natural and fluorinated lipopeptides were compared by 
measuring the minimum inhibitory concentration (MIC) with the fungus Trichophyton 
rubrum using the broth dilution method.  Commercially available iturin A (Sigma) had an 
MIC of 64 µg/mL, whereas purified C-14 iturin A and a mixture of C-14 iturin/fluoroiturin A 
had an MIC of 32 µg/mL.  This difference might be accounted for by the presence of a 
mixture of different fatty acyl chain lengths in the commercially available material (C-14, C-
15 and C-16) and, by extension, suggests that C-14 iturin A is more potent that those 
derivatives with longer chain lengths.  Fengycin (C-16 and C-17) and its fluorinated 
derivatives did not inhibit T. rubrum at the highest concentrations employed for the assay (64 
µg/mL) and owing to the limited amount of material available, no additional concentrations 
were tested.   
 
Conclusions 
Feeding 3-fluoro-L-tyrosine to cultures of Bacillus sp. CS93 resulted in the biosynthesis of 
fluorinated iturins and fengycins.  The fluorinated amino acid was incorporated in place of 
the tyrosine residue in iturin and either tyrosyl residue in fengycin.  2-Fluorotyrosine was not 
incorporated into either lipopeptide, but trace amounts of 4-fluorophenylalanine and 2,3-
difluorotyrosine were incorporated into iturin A and fengycin, respectively.  Bioassay of the 
anti-fungal properties of fluoro-iturin A and mono-fluorofengycin indicated that the presence 
of fluorine did not dramatically alter potency.  Nevertheless, the fluorinated lipopeptides have 
potential application for probing the interaction with membranes via 19F NMR. 
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Fig 3.  Tandem MS of fluorinated C-16 fengycin (A) and key ions formed upon fragmentation 
of the lipopeptide (B) and the lactone portion (C) ions compared with the naturally produced 
analogue. [For tandem MS the ion selected for fragmentation was m/z = 1482.05 and ion current 
used was 2.79 x 103]. 
11 
 
Experimental 
General methods 
NMR spectra were collected using either a Bruker Avance 400 MHz, a Varian Inova 400 MHz 
or a Varian VNMRS 600 MHz spectrometer , multiplicities; s = singlet, d = doublet, dd = 
doublet of doublets, dt, doublet of triplets, m = multiplet, t = triplet, q = quartet, bd = broad 
doublet, bs = broad singlet, app. s = apparent singlet, app. d = apparent doublet, app. t = 
apparent triplet. Chemical shifts are reported in ppm and are referenced to residual solvent 
peaks; J couplings are measured in Hertz (Hz).  All reported yields refer to the isolated yield 
and the product purity was estimated to be >95% by 1H NMR.  Electrospray-ionisation mass 
spectrometry was conducted using a Waters Q-tof Premier coupled to a Waters Alliance 2695 
solvent delivery system. Optical rotations were measured with a Jasco P-1020 polarimeter. 
 Bacillus sp. CS93 was obtained from the Microbial Genomics and Bioprocessing 
Research Unit, National Centre for Agricultural Utilization Research, Peoria, IL. All media 
components were purchased from Sigma-Aldrich. 3-Fluoro-L-tyrosine was purchased from 
Fluorochem, Derbyshire, UK. Fluoro-phenylalanines were supplied by High Force Research 
Limited, Durham, UK. 
 
Feeding studies 
Bacillus sp. CS93 was grown for 72 h in 250mL Erlenmeyer flasks containing a medium 
optimal for lipopeptide production consisting of (g L-1) peptone (30), sucrose (20), yeast extract 
(7), KH2PO4 (1.9), MnSO4.H2O (0.0036) MgSO4 (0.45), C6H8O7 (0.01), CuSO4 (1  10-6), 
FeCl.6H2O (5  10-6), Na2MoO4 (4  10-6), KI (2  10-6), ZnSO4.7H2O (1.4  10-4), H3BO3 (1 
 10-5), as described by Ahimou et al.(2000) Fluorinated tyrosines (2 mM) were introduced to 
the cultures after 24 h incubation.  For up-scale experiments, 20 Erlenmeyer flasks were 
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employed.  To extract the lipopeptides the culture supernatants were harvested by 
centrifugation, acidified to pH 2 and the resulting precipitate was extracted with methanol.  The 
crude lipopeptide fraction was further purified by elution from a Hypersep C-18 solid-phase 
extraction column (Supelco) using a step-wise water:methanol gradient and semi-preparative 
HPLC on a Varian Prostar system.  Iturins were eluted from a SigmaAcentis C-18 column (10 
x 150 mm 5 μm) with 35 % MeCN: water (3.6 mL min-1) and fengycins were eluted from an 
Agilent Zorbax StableBond column (9 x 150 mm 5 μm) column with 40 % MeCN: water (4 
mL min-1). 
 
Antimicrobial assay 
Antifungal susceptibility testing to determine the Minimum Inhibitory Concentration (MIC) 
was conducted using the broth micro-dilution procedure in 96-well plates, according to 
guidelines set out by CLSI (2008).  The MIC at which no growth was observed (MIC) was 
determined by changes in absorbance (530 nm) for up to seven days for T. rubrum. All 
experiments were conducted in triplicate on triplicate samples. 
 
Fluorotyrosine synthesis 
Boc-Ser-OBn (1) 
L-serine (0.67 g, 1.00 eq) was stirred at room temperature in THF (20 mL), H2O (10mL). The 
solution was treated first with 10% aqueous NaOH (20 mL) and then boc anhydride (di-tert-
butyl dicarbonate) (1.13 g, 1.20 eq). The reaction mixture was left to stir at room temperature 
for 20 h and THF was removed under reduced pressure. The resulting solution was acidified to 
pH 2 with 10% citric acid and extracted with ethyl acetate (EtOAc) (3 x 50 mL). The combined 
organic extracts were washed with H2O and dried over MgSO4. Filtration and evaporation 
yielded the Boc-protected amino acid as a clear oil.  Boc-Ser-OH (1.53 g, 1.00 eq), benzyl 
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bromide (0.98 mL, 1.10 eq) and K2CO3 (1.13 g, 1.10 eq) were dissolved in DMF (30 mL) and 
stirred for 20 h at room temperature. H2O (150 mL) was added to the reaction mixture and the 
aqueous phase was extracted with ether (3 x 60 mL). The combined organic extracts were 
washed with brine (2 x 50mL), dried over MgSO4 and evaporated under reduced pressure to 
yield 1 as white powder (1.71 g, 78%). δH (400 MHz; CDCl3) 1.44 (9H, s, tBu), 3.95 (2H, m, 
β-CH2), 4.43 (1H, m, α-CH), 5.21 (2H, m, CH2Ar), 5.48 (1H, m, NH) 7.29 - 7.41 (5H, m, ArH); 
m/z (ESI+) 318.1 (M + Na+) 
Data obtained is consistent with that given in the literature (Friscourt et al. 2012).  
Boc-AlaI-OBn (2) 
1 (0.70 g, 1.00 eq), I2 (0.60 g. 1.00 eq), imidazole (0.16 g, 1.00 eq) and PPh3 (0.62 g, 1.00 eq) 
were dissolved in DCM (25mL) and stirred for 20 h at room temperature. The reaction mixture 
was evaporated under reduced pressure and purified via column chromatography (SiO2; 95/5% 
hexane/EtOAc → 40/60% hexane/EtOAc) to yield the product 2 as pale yellow powder (0.71 
g, 73%). δH (400 MHz; CDCl3) 1.45 (9H, s, tBu), 3.58 (2H, m, β-CH2), 4.56 (1H, m, α-CH), 
5.22 (2H, m, CH2Ar), 5.27 (1H, d, J 7.6, NH) 7.33 - 7.48 (5H, m, ArH); m/z (ESI
+) 427.9 (M 
+ Na+) 
Data obtained is consistent with that given in the literature (Koseki et al. 2011). 
4-(Benzyloxy)-1-bromo-2-fluorobenzene (3) 
4-Bromo-3-fluorophenol (0.333 g, 1.00 eq), benzyl bromide (0.230 mL, 1.10 eq) and K2CO3 
(0.289 g, 1.20 eq) was stirred in MeCN (25 mL) for 20 h at room temperature. The reaction 
mixture was evaporated under reduced pressure and purified via column chromatography 
(SiO2; 95/5% hexane/EtOAc → 40/60% hexane/EtOAc) to yield the product as colourless oil 
(0.276 g, 58%). δH (400 MHz; CDCl3) 5.04 (2H, s, CH2Ar), 6.68 (1H, m, ArH), 6.78 (1H, m, 
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ArH), 7.30-7.45 (6H, m, ArH); δF (376 MHz; CDCl3) -105.14 (1F, t, J 9.2, ArF); m/z (ESI-)  
278.9 (M - H+ , 79Br) 
Data obtained is consistent with that given in the literature (Cowling et al. 2001). 
4-(Benzyloxy)-1-bromo-2,3-difluorobenzene (4) 
4-Bromo-2,3-difluorophenol (0.311 g, 1.00 eq), benzyl bromide (0.200 mL, 1.10 eq) and 
K2CO3 (0.254 g, 1.20 eq) was stirred in MeCN (25 mL) for 20 h at room temperature. The 
reaction mixture was evaporated under reduced pressure and purified via column 
chromatography (SiO2; 95/5% hexane/EtOAc → 40/60% hexane/EtOAc) to yield the product 
as a colourless oil (0.350 g, 77%). δH (400 MHz; CDCl3) 5.18 (2H, s, CH2Ar), 6.85 (1H, m, 
ArH), 7.23 - 7.30 (1H, m, ArH), 7.38 (3H, m, ArH), 7.52 (1H, m, ArH); δF (376 MHz; CDCl3) 
-136.1 (1F, m, ArF), -149.4 (1F, m, ArF); m/z (ESI-)  296.9 (M - H+ , 79Br). 
Data obtained is consistent with that given in the literature (Stensrud et al., 2008). 
Boc-2-F-Tyr-OBn (5) 
Acid washed zinc dust (0.187 g, 4.00 eq) was vigorously stirred and heated under vacuum at 
100°C for 30min. The reaction mixture was cooled to 70°C and placed under positive pressure 
of argon, I2 (0.010 g, 0.01 eq) in anhydrous DMF (0.5 mL) was added. The light grey 
suspension was stirred for 20 min. The reaction mixture was cooled to 50°C at which point 
Boc-AlaI-OBn (2) (0.291 g, 1.00 eq) in DMF (0.8 mL) was added. Stirring under argon 
continued for 20 min. Addition of 4-(benzyloxy)-1-bromo-2-fluorobenzene (3) (0.200 g, 1.00 
eq), Pd2(dba)3 (0.015 g, 0.02 eq)  and SPhos (0.025 g, 0.07 eq). The reaction mixture was left 
to stir at room temperature for 20 h in an argon atmosphere. The reaction mixture was purified 
via column chromatography (SiO2; 98/2% hexane/EtOAc → 50/50% hexane/EtOAc) to yield 
5 as a yellow powder (0.250 g, 72%). vmax(solid)/cm
-1 3364, 2976, 1732, 1687; [α]D29 -11.8 (c 
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1.0, CHCl3); δH (400 MHz; CDCl3) 1.41 (9H, s, tBu), 3.10 (2H, m, β-CH2), 4.58 (1H, m, α-
CH), 5.00 (2H, s, CH2Ar), 5.05 (1H, m, NH), 5.14 (2H, s, CH2Ar), 6.62 - 6.68 (2H, m, ArH) 
6.94 (1H, t, J 9.0, ArH), 7.30 - 7.44 (10H, m, ArH); δF (376 MHz; CDCl3) -115.0 (1F, m, ArF); 
δC (150 MHz; CDCl3) 18.8, 28.4, 54.0, 67.4, 70.5, 80.0, 102.6 (d J 22.5), 110.9 (d, J 3.0), 115.2 
(d, J 15.0), 127.6, 128.3, 128.55, 128.61, 128.7, 128.80, 132.1 (d, J 4.5), 135.4, 136.6, 155.2, 
159.3 (m), 161.9 (d, J 208.5), 171.8; HRMS m/z (ESI+) 502.1994 (M + Na+. C28H30NO5F 
requires 502.2006). 
Boc-2,3-F-Tyr-OBn (6) 
Acid washed zinc dust (0.187 g, 4.00 eq) was vigorously stirred and heated under vacuum at 
100°C for 30 min. The reaction mixture was cooled to 70°C and placed under positive pressure 
of argon, I2 (0.010 g, 0.01 eq) in anhydrous DMF (0.5 mL) was added. The light grey 
suspension was stirred for 20 min. The reaction mixture was cooled to 50°C at which point 
Boc-AlaI-OBn (2) (0.291 g, 1.00 eq) in DMF (0.8 mL) was added. Stirring under argon 
continued for 20 min. Addition of 4-(benzyloxy)-1-bromo-2,3-difluorobenzene (4) (0.300 g, 
1.00 eq), Pd2(dba)3 (0.015 g, 0.02 eq)  and SPhos (0.025 g, 0.07 eq). The reaction mixture is 
left to stir at room temperature for 20 h in an argon atmosphere. The reaction mixture was 
purified via column chromatography (SiO2; 98/2% hexane/EtOAc → 50/50% hexane/EtOAc) 
to yield 5 as brown oil (0.295 g, 60%). vmax(solid)/cm
-1 3377, 2965, 1737, 1686; [α]D29 -19.4 (c 
1.0, CHCl3); δH (400 MHz; CDCl3) 1.40 (9H, s, tBu), 2.96 (2H, m, β-CH2), 4.55 (1H, m, α-
CH), 5.05 - 5.24 (4H, m, 2 x CH2Ar), 5.06 (1H, m, NH), 6.72 - 6.80 (2H, m, ArH), 7.23 - 7.45 
(10H, m, ArH); δF (376 MHz; CDCl3) -137.5 (1F, m, ArF), -153.0 (1F, m, ArF); δC (150 MHz; 
CDCl3) 18.8, 28.4, 54.1, 67.2, 75.8, 80.0, 111.2 (d, J 13.5), 124.9 (m), 126.2 (br s), 128.4, 
128.50, 128.6, 128.66, 128.69, 128.73, 135.4, 136.5, 144.3 (dd, J 11.3, 213.0), 146.1 (d, J 6.0), 
150.8 (dd, J 9.0, 211.5), 155.2, 171.8; HRMS m/z (ESI+) 520.1921 (M + Na+. C28H29NO5F2 
requires 520.1912). 
16 
 
2-F-Tyr-OH (7) 
Boc-2-F-Tyr-OBn 5 (60 mg) was dissolved in 25 mL methanol and stirred in conc. HCl (4 mL) 
for 1 h. Reaction progress was monitored by TLC (90/10% hexane:EtOAc) until completion. 
The mixture was dried by rotary evaporation and dissolved in minimum amount of methanol 
required. Hydrogenation with 20 mg Pd(0) stirring in HCl for 24 h yielding the Boc-deprotected 
product as a brown powder.  2-F-Tyr-OMe (30 mg) was treated with base (KOH; MeOH:H2O, 
4:1) with stirring for 24 hours. The pH was neutralised yielding 20 mg (71%) of product 7 after 
HPLC purification. δH (400 MHz; d4-methanol) 3.19 (2H,  m, β-CH2), 4.10 (1H, t, J 6.6, α-
CH),  6.52 - 6.63 (2H, m, ArH), 7.12 (1H, t, J 9.0, ArH), δF (400 MHz; d4-methanol) -121.5 
(1F, t, J 10.0, ArF); HRMS m/z (ESI+) 200.0726 (M + H+. C9H11FNO3 requires 200.0723) 
Data obtained are consistent with those given in the literature (Kim et al. 1998). 
 
2,3-F-Tyr-OH (8) 
Boc-2,3-F-Tyr-OBn 6 (60 mg) was dissolved in 25 mL methanol and stirred in conc. HCl (4 
mL) for 1 hour.  Reaction progress was monitored by TLC (90/10% hexane:EtOAc) until 
completion. The mixture was dried by rotary evaporation and dissolved in minimum amount 
of methanol required. Hydrogenation with 20 mg Pd(0) stirring in HCl for 24 h yielding the 
Boc-deprotected product as a brown powder.  2,3-F-Tyr-OMe (30 mg) was treated with base 
(KOH; MeOH:H2O, 4:1) with stirring for 24 hours. The pH was neutralised yielding 16 mg 
(57%) product 8 after HPLC purification. δH (400 MHz; d4-methanol) 3.17 (2H, m, β-CH2), 
4.10 (1H, t, J  6.6, α-CH), 6.68 (1H, m, ArH), 6.93 (1H, m, ArH); δF (400 MHz; d4-methanol) 
-141.4 (1F, m, ArF), -163.6 (1F, m, ArF); HRMS m/z (ESI+) 218.0635 (M + H+. C9H10F2NO3 
requires 218.0629) 
Data obtained are consistent with those given in the literature (Kim et al. 1998). 
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